A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18-26 years

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Giambi, Cristina ^a   Donati, Serena ^a   Carozzi, Francesca ^b   Salmaso, Stefania ^a   Declich, Silvia ^a   Atti, Marta L Ciofi degli ^c   Ronco, Guglielmo ^d   Alibrandi, Maria P ^e   Brezzi, Silvia ^f   Collina, Natalina ^g   Franchi, Daniela ^h   Lattanzi, Amedeo ⁱ   Minna, Maria C ^j   Nannini, Roberto ^k   Barretta, Elena ^l   Burroni, Elena ^b   Gillio Tos, Anna ^m   Macallini, Vincenzo ⁿ   Pierotti, Paola ^o   Bella, Antonino ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d Center for Cancer Prevention   (Italy)

^e Hygiene and Public Health Unit   (Italy)

^f LHU Viterbo   (Italy)

^g LHU Bologna   (Italy)

^h Department of Prevention   (Italy)

ⁱ San Liberatore Hospital   (Italy)

^j LHU Pescara ^*  (Italy)

^k Oncologic Screening Center   (Italy)

^l Mother and Child Department   (Italy)

^m UNIVERSITY OF TURIN   (Italy)

ⁿ S Rinaldi Hospital   (Italy)

^o MAGGIORE HOSPITAL   (Italy)

more..

Author keywords

Cervical cancer; Genotype distribution; High risk types; Human papillomavirus; Italy; Prevalence; Risk factors

Indexed keywords

ADULT; AGE; ARTICLE; CONDOM; CONDYLOMA ACUMINATUM; CONTRACEPTION; CROSS-SECTIONAL STUDY; DEMOGRAPHY; ETHNIC GROUP; FEMALE; GENOTYPE; HEALTH CENTER; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 66; INFECTION RISK; ITALIAN; ITALY; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PREVALENCE; RISK FACTOR; SEXUAL BEHAVIOR; URBAN RURAL DIFFERENCE; UTERINE CERVIX CYTOLOGY; VIRUS TYPING; WART VIRUS; ADOLESCENT; ALPHAPAPILLOMAVIRUS; ANALYSIS OF VARIANCE; CHI SQUARE DISTRIBUTION; CLASSIFICATION; GENETICS; ISOLATION AND PURIFICATION; PAPILLOMAVIRUS INFECTIONS; PATHOGENICITY; VIROLOGY;

ADOLESCENT; ADULT; ALPHAPAPILLOMAVIRUS; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; ITALY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS;

EID: 84873390229     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-74     Document Type: Article

References (38)

1. Bosch FX, Lorincz A, Muñoz N, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55:244-265. 10.1136/jcp.55.4.244, 1769629, 11919208.
2. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol 2005, 32S:S16-S24.
3. World Health Organization position paper Human papillomavirus vaccines. Weekly epidemiological record 2009, 15(84):117-132. Available at: http://www.who.int/wer/2009/wer8415.pdf. Accessed 4 May 2012, World Health Organization position paper.
4. Mariani L, Monfulleda N, Alemany L, Vizza E, Marandino F, Vocaturo A. Human Papilloma Virus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy. BMC Cancer 2010, 10:259. 10.1186/1471-2407-10-259, 2898696, 20525370.
5. Dorleans F, Giambi C, Dematte L, Cotter S, Stefanoff P, Mereckiene J. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey?. Euro Surveill 2010, 15(47). Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19730. Accessed 4 May 2012.
6. Presidency of the Council State-Regions Agreement " Strategies for HPV Vaccination Active Offer in Italy" 2007, Italian, Available at: http://www.statoregioni.it/Documenti/DOC_016696_264%20csr.pdf. Accessed 4 May 2012, Presidency of the Council.
7. Giambi C. Progresses of HPV Vaccination Campaign: Vaccination Coverage Data at 31/12/2011 Available at: http://www.epicentro.iss.it/problemi/hpv/pdf/Aggiornamento_datiHPV_31_12_2011_validato.pdf. Accessed 18 May 2012.
8. Ronco G, Brezzi S, Carozzi F, Dalla Palma P, Giorgi-Rossi P, Minucci D. NTCC study group. The New technologies for cervical cancer screening randomized controlled trial. An overview of results during the first phase of recruitment. Gynecol Oncol 2007, 107:S230-S232. 10.1016/j.ygyno.2007.07.021, 17822751.
9. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, NTCC Working Group Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomized controlled trial. Lancet Oncol 2010, 11:249-257. 10.1016/S1470-2045(09)70360-2, 20089449, NTCC Working Group.
10. Giorgi-Rossi P, Bisanzi S, Paganini I, Di Iasi A, Angeloni C, Scalisi A, HPV Prevalence Italian Working Group Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study. BMC Infect Dis 2010, 10:214. 2916912, 20646310, HPV Prevalence Italian Working Group.
11. Confortini M, Carozzi F, Zappa M, Ventura L, Iossa A, Cariaggi P. Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18-24: results at recruitment. BMC Infect Dis 2010, 10:157. 10.1186/1471-2334-10-157, 2898819, 20529280.
12. Ammatuna P, Giovannelli L, Matranga D, Ciriminna S, Perino A. Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy. Cancer Epidemiol Biomarkers Prev 2008, 17:2002-2006. 10.1158/1055-9965.EPI-08-0180, 18708390.
13. Donati A, Giambi S, Declich S, Salmaso S, Filia A, Atti ML C, The PreGio Working group Knowledge, attitude and practice in primary and secondary cervical cancer prevention among young adult Italian women. Vaccine 2012, 30:2075-2082. 10.1016/j.vaccine.2012.01.057, 22300719, The PreGio Working group.
14. Giambi C, Donati S, Declich S, Salmaso S, Atti ML C, Alibrandi MP, The PreGio Working Group Estimated acceptance of HPV vaccination among Italian women aged 18-26 years. Vaccine 2011, 29:8373-8380. 10.1016/j.vaccine.2011.08.079, 21872630, The PreGio Working Group.
15. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Forum Group Members and Bethesda 2001 Workshop The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002, 287:2114-2119. 10.1001/jama.287.16.2114, 11966386, Forum Group Members and Bethesda 2001 Workshop.
16. Carozzi F, Del Mistro A, Confortini M, Sani C, Puliti D, Trevisan R. Reproducibility of HPV DNA testing by hybrid capture 2 in a screening setting: intralaboratory and interlaboratory quality control in seven laboratories participating in the same clinical trial. Am J Clin Pathol 2005, 124:1-6.
17. Castle PE, Schiffman M, Burk RD, Wacholder S, Hildesheim A, Herrero R. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev 2002, 11:1394-1399.
18. Castle PE, Solomon D, Wheeler CM, Gravitt PE, Wacholder S, Shiffman M. Human Papillomavirus genotype specificity of Hybrid Capture 2. J Clin Microbiol 2008, 46:2595-2604. 10.1128/JCM.00824-08, 2519476, 18579716.
19. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008, 26S:K1-K16.
20. Ripabelli G, Grasso GM, Del Riccio I, Tamburro M, Sammarco ML. Prevalence and genotype identification of human papilloma virus in women undergoing voluntary cervical cancer screening in Molise, central Italy. Cancer Epidemiology 2010, 34(2):162-167. 10.1016/j.canep.2009.12.010, 20080070.
21. Masia G, Mazzoleni AP, Contu G, Laconi S, Minerba L, Montixi S. Epidemiology and genotype distribution of human papillomavirus (HPV) in women of Sardinia (Italy). Vaccine 2009, 27:A11-A16.
22. Agarossi A, Ferrazzi E, Parazzini F, Perno CF, Ghisoni L. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. J Med Virol 2009, 81:529-535. 10.1002/jmv.21347, 19152401.
23. Ronco G, Giubilato P, Naldoni C, Zorzi M, Anghinoni E, Scalisi A. Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2009 activity. Epidemiol Prev 2011, 35(Suppl. 5):39-54. 5-6.
24. De Sanjosè S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007, 7:453-459. 10.1016/S1473-3099(07)70158-5, 17597569.
25. De Francessco MA, Gargiulo F, Schreiber C, Ciravolo G, Salinaro F, Manca N. Detection and genotyping of human papillomavirus in cervical samples from Italian patients. J Med Virol 2005, 75:588-592. 10.1002/jmv.20306, 15714493.
26. Broccolo F, Chiari S, Piana A, Castiglia P, Dell'Anna T, Garcia-Parra R. Prevalence and viral load of oncogenic human papilloma virus types associated with cervical carcinoma in a population of North Italy. J Med Virol 2009, 83:278-287.
27. Agodi A, Barchitta M, La Rosa N, Cipresso R, Guarnaccia M, Caruso M. Human papillomavirus infection. Low-risk and high risk genotypes in women in Catania, Sicily. Int J Gynecol Cancer 2009, 19:1094-1098. 10.1111/IGC.0b013e3181a83c9d, 19820375.
28. Piana A, Sotgiu G, Castiglia P, Pischedda S, Cocuzza C, Capobianco G. Prevalence and type distribution of human papillomavirus infection in women from North Sardinia, Italy. BMC Publ Health 2011, 11:785.
29. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, on behalf of the WHO International Agency for Research on Cancer Monograph Working Group Special report: policy. A review of human carcinogens-part B: biological agents. Lancet Oncol 2009, 10(4):321-322. 10.1016/S1470-2045(09)70096-8, 19350698, on behalf of the WHO International Agency for Research on Cancer Monograph Working Group.
30. Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, Carozzi F. Human papillomavirus testing and liquid-based cytology in primary cervical screening: results at recruitment from the New technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst 2006, 98:765-774. 10.1093/jnci/djj209, 16757701.
31. Ronco G, Giorgi-Rossi P, Carozzi F, Dalla Palma P, Del Mistro A, De Marco L, NTCC Working Group Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol 2006, 7:547-555. 10.1016/S1470-2045(06)70731-8, 16814206, NTCC Working Group.
32. Giorgi-Rossi P, Chini F, Bisanzi S, Burroni E, Carillo G, Lattanzi A, The Prevalence Italian Working Group HPV Distribution of high and low risk HPV types by cytological status: a population based study from Italy. Infectious Agents and Cancer 2011, 6:2. 10.1186/1750-9378-6-2, 3038961, 21247508, The Prevalence Italian Working Group HPV.
33. Shiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human paillomavirus and cervical cancer. Lancet 2007, 370:890-907. 10.1016/S0140-6736(07)61416-0, 17826171.
34. Lenselink CH, Melchers WJ, Quint WG, Hoebers AM, Hendriks JC, Massuger LF, Bekkers RL. Sexual behaviour and HPV infections in 18 to 29 year old women in the pre-vaccine era in the Netherlands. PLoS One 2008, 3(11):e3743. Epub 2008 Nov 17, 10.1371/journal.pone.0003743, 2581437, 19011683.
35. Skjeldestad FE, Mehta V, Sings HL, Øvreness T, Turpin J, Su L. Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women: study design and cohort characteristics. Acta Obstet Gynecol Scand 2008, 87(1):81-88. 10.1080/00016340701714703, 17943470.
36. Martín P, Kilany L, García D, López-García AM, Martín-Azaña MJ, Abraira V. Human papillomavirus genotype distribution in Madrid and correlation with cytological data. BMC Infect Dis 2011, 11:316. 10.1186/1471-2334-11-316, 3231944, 22081930.
37. Karlsson R, Jonsson M, Edlund K, Evander M, Gustavsson A, Bodén E, Rylander E. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex Transm Dis 1995, 22(2):119-127. 10.1097/00007435-199503000-00008, 7624813.
38. Ronco G, Ghisetti V, Segnan N, Snijders PJ, Gillio-Tos A, Meijer CJ. Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer 2005, 41(2):297-305. 10.1016/j.ejca.2004.07.005, 15661556.